Solid Biosciences Management
Management criteria checks 2/4
Solid Biosciences' CEO ist Bo Cumbo , ernannt in Dec 2022, hat eine Amtszeit von 1.08 Jahren. Die jährliche Gesamtvergütung beträgt $3.98M , bestehend aus 1.1% Gehalt und 98.9% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.086% der Aktien des Unternehmens, im Wert von $107.08K . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 2 Jahre bzw. 6.4 Jahre.
Key information
Bo Cumbo
Chief executive officer
US$4.0m
Total compensation
CEO salary percentage | 1.1% |
CEO tenure | 1.3yrs |
CEO ownership | 0.05% |
Management average tenure | 2.3yrs |
Board average tenure | 6.7yrs |
Recent management updates
Recent updates
Solid Biosciences: DMD Treatment Advancement With Next-Generation Capsid
Jan 17Solid Biosciences to acquire gene therapy company AavantiBio
Sep 30Analysts Have Lowered Expectations For Solid Biosciences Inc. (NASDAQ:SLDB) After Its Latest Results
Apr 30Some Analysts Just Cut Their Solid Biosciences Inc. (NASDAQ:SLDB) Estimates
Apr 28We're Keeping An Eye On Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate
Mar 17Solid Biosciences (NASDAQ:SLDB) Is In A Good Position To Deliver On Growth Plans
Oct 28We're Not Very Worried About Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate
Jul 13We're Hopeful That Solid Biosciences (NASDAQ:SLDB) Will Use Its Cash Wisely
Mar 17Soild Bio sinks 13% after Sarepta data misses goal
Jan 08Solid Biosciences launches $90M private placement
Dec 11Solid Biosciences: Does Not Look Like A Solid Investment Given Its Unsatisfactory Trial Data
Nov 10CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -US$96m |
Sep 30 2023 | n/a | n/a | -US$91m |
Jun 30 2023 | n/a | n/a | -US$90m |
Mar 31 2023 | n/a | n/a | -US$91m |
Dec 31 2022 | US$4m | US$46k | -US$86m |
Vergütung im Vergleich zum Markt: BoDie Gesamtvergütung ($USD3.98M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD738.70K).
Entschädigung vs. Einkommen: Unzureichende Daten, um die Vergütung von Bo mit der Unternehmensleistung zu vergleichen.
CEO
Bo Cumbo (52 yo)
1.3yrs
Tenure
US$3,975,453
Compensation
Mr. Alexander G. Cumbo, also known as Bo, serves as President, Chief Executive Officer and Director at Solid Biosciences Inc. since December 02, 2022. He serves as its Director of Verve Therapeutics, Inc....
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chair | 4yrs | US$637.80k | 0.26% $ 1.3m | |
President | 1.3yrs | US$3.98m | 0.046% $ 218.3k | |
Co-founder | 11.3yrs | US$2.21m | 0.32% $ 1.5m | |
COO & Secretary | 1.3yrs | US$2.38m | 0.020% $ 96.2k | |
Co-Founder | 11.3yrs | no data | no data | |
Co-Founder & Head of Patient Advocacy | no data | no data | no data | |
Co-Founder | 11.3yrs | US$125.76k | no data | |
CFO & Treasurer | 1.3yrs | no data | 0.025% $ 116.5k | |
Treasurer & Principal Accounting Officer | 3.3yrs | no data | no data | |
Chief Technology Officer | 1.3yrs | no data | 0.016% $ 75.4k | |
Chief Scientific Officer | less than a year | no data | 0.019% $ 87.6k | |
Senior Vice President of Human Resources | 2.3yrs | no data | no data |
2.3yrs
Average Tenure
51.5yo
Average Age
Erfahrenes Management: SLDBDas Führungsteam des Unternehmens gilt als erfahren (2 Jahre durchschnittliche Betriebszugehörigkeit).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chair | 4yrs | US$637.80k | 0.26% $ 1.3m | |
President | 1.3yrs | US$3.98m | 0.046% $ 218.3k | |
Co-founder | 11.3yrs | US$2.21m | 0.32% $ 1.5m | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 7.1yrs | US$130.95k | no data | |
Director | 1.3yrs | US$102.14k | no data | |
Chairman of Scientific Advisory Board | 6.3yrs | no data | no data | |
Lead Independent Director | 8.4yrs | US$137.53k | 0% $ 0 | |
Independent Director | 8.4yrs | US$142.11k | 0% $ 0 | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data |
6.7yrs
Average Tenure
52.5yo
Average Age
Erfahrener Vorstand: SLDBDie Vorstandsmitglieder gelten als erfahren (6.3 Jahre durchschnittliche Amtszeit).